Establishing treatment guidelines, improving capacity to monitor antimicrobial susceptibility, and adequate supply of quality medications are key strategies to slow the spread of resistant gonorrhoea. Advances in the public health and clinical management of N gonorrhoeae stem from basic research on the biology of the organism, the development of diagnostic capabilities, and the availability of more effective drugs. The “bench to practise” translation of this research is vital to building capacity.
This presentation will focus on the gonorrhoea resistance research and training opportunities to contribute to the prevention and control efforts.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.